Hou, Changlong
Xiong, Baizhu
Zhou, Lei
Fei, Yipeng
Shi, Changgao
Zhu, Xianhai
Xie, Tao
Wu, Yulin
Funding for this research was provided by:
National Cancer Center Climbing Foundation (NO.NCC 201912B01)
China International Medical Foundation (NO. Z-2014-06-2103)
Article History
Received: 4 February 2024
Accepted: 19 March 2024
First Online: 27 March 2024
Declarations
:
: The authors declare no competing interests.
: The study protocol was approved by the ethics committee of the First Affiliated Hospital of University of Science and Technology of China (approval number: 2023-JRK-03) and individual informed consent for this study was waived for this retrospective analysis. But all patients provided written informed consent for the treatment they received. All procedures were conducted in accordance with the principles outlined in the Declaration of Helsinki.
: Not applicable.